News
MRNA
--
0.00%
--
The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs
Biotech stocks reversed course in the week ended April 16, with the sector rebounding along with the broader market. The week's news flow was fairly light. The American Association of Cancer Research's annual meeting provided a platform for oncology-focuse...
Benzinga · 7h ago
Moderna cuts UK COVID vaccine deliveries as pregnant women told mRNA jabs are safe
The Moderna jab, which works in a similar way to the Pfizer vaccine, uses synthetic messenger RNA (mRNA) technology that can be quickly tweaked to address new mutations of a virus.
Yahoo Finance UK · 8h ago
Coronavirus Vaccine Plays Moderna, Maravai, West Pharmaceutical Among 5 Stocks Near Buy Points
Investor's Business Daily · 8h ago
Australia Posts Third AstraZeneca-Linked Death: Virus Update
Bloomberg · 15h ago
J&J, Morgan Stanley, Coinbase: Stocks That Defined the Week
Here are major companies whose stocks moved on the week’s news.
marketwatch.com · 21h ago
How much money will Pfizer and Moderna make from their booster shots?
Quartz · 23h ago
Senators urge Biden to back temporary WTO waiver of IP rights to speed vaccine access
reuters.com · 1d ago
DJ Vaccine Manufacturing Issues Force Moderna to Cut Supplies to Canada, U.K.
Dow Jones · 1d ago
Moderna, Pfizer vaccine allocations to rise next week as J&J shot suspended
Data from the Centers for Disease Control and Prevention ("CDC") indicates that states will see a modest increase in COVID-19 vaccines from Moderna (MRNA) and Pfizer (PFE) allocated from the
Seekingalpha · 1d ago
U.S. administers 202.3 mln doses of COVID-19 vaccines - CDC
reuters.com · 1d ago
Dow Jones Rally Led By Cisco Systems; Moderna Soars 7%, Tops Nasdaq 100 Performance
Investor's Business Daily · 1d ago
BRIEF-U.S. CDC Says Delivered 258,502,815 Doses Of COVID-19 Vaccine As Of April 16
reuters.com · 1d ago
UPDATE 1-Pregnant women in UK told to have Pfizer or Moderna vaccines
reuters.com · 1d ago
UPDATE 1-Madrid may shut down mass vaccination centres unless more shots arrive
reuters.com · 1d ago
U.S. Has Administered More Than 200M Vaccine Doses
-Bloomberg
Bloomberg · 1d ago
Moderna sees shortfall in Britain COVID vaccine shipments, EU deliveries on track
reuters.com · 1d ago
Pregnant women in UK should have Pfizer or Moderna vaccines, advisory body says
reuters.com · 1d ago
Jaguar Holding Company II, LLC -- Moody's places PPD's ratings under review for upgrade on proposed acquisition by Thermo Fisher
Rating Action: Moody's places PPD's ratings under review for upgrade on proposed acquisition by Thermo FisherGlobal Credit Research - 16 Apr 2021New York, April 16, 2021 -- Moody's Investors Service, ("Moody's") placed the ratings of PPD, Inc. and its subs...
Moody's · 1d ago
Moderna cutting vaccine deliveries to Canada, but Pfizer adding doses - CBC
Canada will receive just 650K COVID-19 shots from Moderna (MRNA) instead of a previously anticipated 1.2M doses this month as the company deals with production issues at European facilities, according
Seekingalpha · 1d ago
Moderna Says Shortfall In Estimated COVID-19 Vaccine Doses From European Supply Chain Will Force Adjustment TO Q2 Delivery Quantities For Canada, Britain
-Reuters
Reuters · 1d ago
Webull provides a variety of real-time MRNA stock news. You can receive the latest news about Moderna through multiple platforms. This information may help you make smarter investment decisions.
About MRNA
Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced in parallel a diverse development pipeline of 21 programs, of which 10 have entered clinical studies and another three have open INDs. Its therapeutics and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases. It has created six modalities prophylactic vaccines, cancer vaccines, intratumoral immmuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics and systemic intracellular therapeutics.